Teng Torrance, Crooker Kyle, Hickey Tess, HoddWells Max, Sarathy Ashwini, Muniz Sean, Lor Jennifer, Chang Amy, Tompkins Bradley J, O'Brien Aaron, Riser Elly, Singh Devika, Dejace Jean, Hale Andrew J
Infectious Disease Unit, University of Vermont Medical Center, 111 Colchester Avenue, Mailstop 115 SM2, Burlington, VT, 05401, USA.
Infect Dis Poverty. 2025 Jun 13;14(1):48. doi: 10.1186/s40249-025-01318-4.
Infective endocarditis (IE) is associated with significant morbidity and mortality and current treatment guidelines recommend a prolonged course of intravenous antibiotics. However, individuals experiencing homelessness face greater barriers to standard IE care. The aim of this study was to compare IE characteristics and outcomes in an unhoused population versus a housed population.
A retrospective cohort study encompassing 2010-2020 was conducted in Burlington, Vermont, comparing characteristics and outcomes of patients with IE who did or did not experience homelessness at the time of their infection. Primary outcomes included 30-day, 90-day, and 365-day mortality, IE-related mortality, and IE-related readmission rates. Secondary outcomes included rates of microbiologic failure and treatment failure.
Of 378 included patients with IE, 30 (7.9%) experienced homelessness and 348 (92.1%) did not. The unhoused cohort was more likely to have right-sided IE involving the tricuspid valve (50.0% vs 21.6%, P = 0.006) and for the causative organism to be methicillin-resistant Staphylococcus aureus (MRSA) [9 (30.0%) vs 43 (12.4%), P = 0.039]. Mortality, IE-related mortality, and IE-related readmission rates were not significantly different between groups at any time point measured. For secondary outcomes, differences in microbiologic failure [5 (16.7%) vs 36 (10.3%), P = 0.543] and treatment failure [9 (30.0%) vs 105 (30.2%), P = 1.000] were also not statistically significant.
Future research should elucidate factors that entail increased risk of poor outcomes in this important underserved population and how to best mitigate them.
感染性心内膜炎(IE)与显著的发病率和死亡率相关,当前的治疗指南推荐采用延长疗程的静脉抗生素治疗。然而,无家可归者在接受标准的IE治疗时面临更大的障碍。本研究的目的是比较无家可归人群与有家可归人群的IE特征和结局。
在佛蒙特州伯灵顿进行了一项回顾性队列研究,涵盖2010年至2020年,比较感染时有无无家可归经历的IE患者的特征和结局。主要结局包括30天、90天和365天死亡率、IE相关死亡率以及IE相关再入院率。次要结局包括微生物学失败率和治疗失败率。
在纳入的378例IE患者中,30例(7.9%)无家可归,348例(92.1%)有家可归。无家可归队列更易发生累及三尖瓣的右侧IE(50.0%对21.6%,P = 0.006),且致病微生物更可能为耐甲氧西林金黄色葡萄球菌(MRSA)[9例(30.0%)对43例(12.4%),P = 0.039]。在任何测量的时间点,两组之间的死亡率、IE相关死亡率和IE相关再入院率均无显著差异。对于次要结局,微生物学失败率[5例(16.7%)对36例(10.3%),P = 0.543]和治疗失败率[9例(30.0%)对105例(30.2%),P = 1.000]的差异也无统计学意义。
未来的研究应阐明导致这一重要的未得到充分服务人群不良结局风险增加的因素,以及如何最好地减轻这些因素的影响。